NewsBenzingaCORRECTION: Addex Therapeutics Q2 EPADS $(2.16) Up From $(2.90) YoY, Sales $12.650K Down From $44.031K YoY CORRECTION: Addex Therapeutics Q2 EPADS $(2.16) Up From $(2.90) YoY, Sales $12.650K Down From $44.031K YoY Benzinga 2026.09.28 14:10 (GMT+0) Open on Benzinga Other news 'Europe’s Top Carriers Explore Satellite Group to Fend Off SpaceX' - Bloomberg HC Wainwright & Co. Reiterates Buy on Zentalis Pharmaceuticals, Maintains $10 Price Target Reported October 16, 'CFP reaches 'handshake agreement' with ESPN to air 24-team playoff, sources say' - ESPN HC Wainwright & Co. Maintains Buy on Enliven Therapeutics, Raises Price Target to $73 Needham Reiterates Buy on Harmony Biosciences Hldgs, Maintains $50 Price Target AI Boom Hits a Power Wall: Microsoft Walks Away From Nscale's UK Data Center Deal
Reported October 16, 'CFP reaches 'handshake agreement' with ESPN to air 24-team playoff, sources say' - ESPN
